Polaris Venture Management Co IV’s Acceleron Pharma XLRN Stock Holding History

Polaris Venture Management Co IV’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$53.6M	Hold	1,480,060	–	–	85.86%	1
2016 Q2	$50.3M	Hold	1,480,060	–	–	83.36%	1
2016 Q1	$39.1M	Hold	1,480,060	–	–	73.52%	1
2015 Q4	$72.2M	Hold	1,480,060	–	–	79.75%	1
2015 Q3	$36.9M	Sell	1,480,060 -407,259	-22%	-$12.2M	64.78%	1
2015 Q2	$59.7M	Sell	1,887,319 -509,070	-21%	-$16.4M	62.12%	1
2015 Q1	$91.2M	Sell	2,396,389 -183,902	-7%	-$7.31M	76.05%	1
2014 Q4	$101M	Sell	2,580,291 -223,354	-8%	-$7.78M	79.21%	1
2014 Q3	$84.8M	Hold	2,803,645	–	–	78.57%	1
2014 Q2	$95.2M	Sell	2,803,645 -513,491	-15%	-$17.2M	77.81%	1
2014 Q1	$114M	Buy	3,317,136 +183,902	+6%	+$8.3M	75.52%	1
2013 Q4	$124M	Buy	+3,133,234	New	+$75.6M	82.43%	1

Other funds holding XLRN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Polaris Venture Management Co IV's XLRN Position: Q3 2016 in Review

Polaris Venture Management Co IV held its Acceleron Pharma (XLRN) position steady in Q3 2016 at 1,480,060 shares worth $53.6M. The position accounts for 85.86% of the portfolio, ranked #1.

Polaris Venture Management Co IV first reported a position in XLRN in Q4 2013 and has held it in 12 quarters since. The position peaked at $124M in Q4 2013. 138 funds tracked by Wall St. Rank hold XLRN as of Q3 2016.

Polaris Venture Management Co IV held 1,480,060 shares of Acceleron Pharma worth $53.6M as of Q3 2016.
Polaris Venture Management Co IV left its Acceleron Pharma share count unchanged in Q3 2016.
Acceleron Pharma made up 85.86% of Polaris Venture Management Co IV's portfolio in Q3 2016, its #1 holding.
Polaris Venture Management Co IV first reported a position in Acceleron Pharma in Q4 2013 and has held it in 12 quarters since.
Polaris Venture Management Co IV's Acceleron Pharma position peaked at $124M in Q4 2013.
138 funds tracked by Wall St. Rank held Acceleron Pharma as of Q3 2016.

Based on Polaris Venture Management Co IV's 13F filing for Q3 2016, filed 14 Feb 2017.